Breed differences in development of anti-insulin antibodies in diabetic dogs and investigation of the role of dog leukocyte antigen (DLA) genes

Veterinary Immunology and Immunopathology

Volumn 167, Issue 3-4, 2015, Pages 130-138

  Holder, Angela L ^a   Kennedy, Lorna J ^b   Ollier, William E R ^b   Catchpole, Brian ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Diabetes mellitus; Dog breeds; Dog leukocyte antigen; Insulin; Major histocompatibility complex; Susceptibility genes

Indexed keywords

AUTOANTIBODY; BOVINE INSULIN; DOG LEUKOCYTE ANTIGEN; GENOMIC DNA; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INSULIN ANTIBODY; LEUKOCYTE ANTIGEN; PIG INSULIN; UNCLASSIFIED DRUG; HISTOCOMPATIBILITY ANTIGEN DLA; HLA ANTIGEN CLASS 1; INSULIN;

ANIMAL GENETICS; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; BLOOD SAMPLING; BREED DIFFERENCE; CONTROLLED STUDY; DACHSHUND (DOG); DIABETES MELLITUS; DLA GENE; DOG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE FUNCTION; GENE SEQUENCE; GENOTYPE; GLYCEMIC CONTROL; HAPLOTYPE; HYBRID DOG; IMMUNOGENICITY; INSULIN TREATMENT; LABRADOR RETRIEVER; NONHUMAN; PATHOGENESIS; SPANIEL; TERRIER; TREATMENT DURATION; ANIMAL; BLOOD; BOVINE; DOG; DOG DISEASES; GENETICS; IMMUNOLOGY; SPECIES DIFFERENCE; VETERINARY;

ANIMALS; CATTLE; DIABETES MELLITUS; DOG DISEASES; DOGS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INSULIN; INSULIN ANTIBODIES; INSULIN, REGULAR, PORK; SPECIES SPECIFICITY;

EID: 84941992638     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2015.07.014     Document Type: Article

References (29)

1. Abiru N., Yu L., Miao D., Maniatis A.K., Liu E., Moriyama H., Eisenbarth G.S. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J. Autoimmun. 2001, 17:1-6.
2. Catchpole B., Adams J.P., Holder A.L., Short A.D., Ollier W.E., Kennedy L.J. Genetics of canine diabetes mellitus: are the diabetes susceptibility genes identified in humans involved in breed susceptibility to diabetes mellitus in dogs?. Vet. J. 2013, 195:139-147.
3. Catchpole B., Kennedy L.J., Davison L.J., Ollier W.E. Canine diabetes mellitus: from phenotype to genotype. J. Small Anim. Pract. 2008, 49:4-10.
4. Catchpole B., Ristic J.M., Fleeman L.M., Davison L.J. Canine diabetes mellitus: can old dogs teach us new tricks?. Diabetologia 2005, 48:1948-1956.
5. Davison L.J., Herrtage M.E., Catchpole B. Study of 253 dogs in the United Kingdom with diabetes mellitus. Vet. Rec. 2005, 156:467-471.
6. Davison L.J., Ristic J.M.E., Herrtage M.E., Ramsey I.K., Catchpole B. Anti-insulin antibodies in dogs with naturally occurring diabetes mellitus. Vet. Immunol. Immunopathol. 2003, 91:53-60.
7. Davison L.J., Walding B., Herrtage M.E., Catchpole B. Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations. J. Vet. Intern. Med. 2008, 22:1317-1325.
8. Duckworth W.C., Bennett R.G., Hamel F.G. Insulin degradation: progress and potential. Endocr. Rev. 1998, 19:608-624.
9. Fineberg S.E., Kawabata T.T., Finco-Kent D., Fountaine R.J., Finch G.L., Krasner A.S. Immunological responses to exogenous insulin. Endocr. Rev. 2007, 28:625-652.
10. Franke B., Galloway T.S., Wilkin T.J. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Diabetes Metab. Res. Rev. 2005, 21:395-415.
11. Hess R.S., Ward C.R. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998). J. Am. Vet. Med. Assoc. 2000, 216:217-221.
12. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol. Cell. Endocrinol. 2002, 197:221-229.
13. Kapp J.A., Strayer D.S. H-2 linked Ir gene control of antibody-responses to porcine insulin. 1. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin. J. Immunol. 1978, 121:978-982.
14. Keck K. Ir gene control of carrier recognition. 1. Immunogenicity of bovine insulin derivatives. Eur. J. Immunol. 1975, 5:801-807.
15. Kennedy L.J., Barnes A., Happ G.M., Quinnell R.J., Bennett D., Angles J.M., Day M.J., Carmichael N., Innes J.F., Isherwood D., Carter S.D., Thomson W., Ollier W.E. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 2002, 59:194-204.
16. Kennedy L.J., Davison L.J., Barnes A., Short A.D., Fretwell N., Jones C.A., Lee A.C., Ollier W.E., Catchpole B. Identification of susceptibility and protective major histocompatibility complex haplotypes in canine diabetes mellitus. Tissue Antigens 2006, 68:467-476.
17. Kwok W.W., Nepom G.T., Raymond F.C. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 1995, 155:2468-2476.
18. Menzel R., Knospe S., Ziegler M., Wilke W., Michael R. Failure of appearance of insulin antibodies in dogs adapted to bovine-porcine insulin. Diabetologia 1971, 7:386-390.
19. O'Sullivan D., Sidney J., Appella E., Walker L., Phillips L., Colon S.M., Miles C., Chesnut R.W., Sette A. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 1990, 145:1799-1808.
20. Pugliese A., Zeller M., Fernandez A., Zalcberg L.J., Bartlett R.J., Ricordi C., Pietropaolo M., Eisenbarth G.S., Bennett S.T., Patel D.D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 1997, 15:293-297.
21. Rand J.S., Fleeman L.M., Farrow H.A., Appleton D.J., Lederer R. Canine and feline diabetes mellitus: nature or nurture?. J. Nutr. 2004, 134:2072S-2080S.
22. Reeves W.G., Barr D., Douglas C.A., Gelsthorpe K., Hanning I., Skene A., Wells L., Wilson R.M., Tattersall R.B. Factors governing the human immune response to injected insulin. Diabetologia 1984, 26:266-271.
23. Reeves W.G., Kelly U. Insulin-antibodies induced by bovine insulin therapy. Clin. Exp. Immunol. 1982, 50:163-170.
24. Rosenwasser L.J., Barcinski M.A., Schwartz R.H., Rosenthal A.S. Immune response gene control of determinant selection. II. Genetic control of the murine T lymphocyte proliferative response to insulin. J. Immunol. 1979, 123:471-476.
25. Schernthaner G., Ludwig H., Mayr W.R. Immunoglobulin G-insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1979, 48:403-407.
26. Sklenar I., Neri T.M., Berger W., Erb P. Association of specific immune-response to pork and beef insulin with certain Hla-Dr antigens in type-1 diabetes. Br. Med. J. 1982, 285:1451-1453.
27. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., Wickramasinghe S., Colle E., Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 1997, 15:289-292.
28. Walford S., Allison S.P., Reeves W.G. The effect of insulin antibodies on insulin dose and diabetic control. Diabetologia 1982, 22:106-110.
29. Webb C.B. Troubleshooting the diabetic small animal patient. Clin. Tech. Small Anim. Pract. 2002, 17:79-85.